Alira Health

Alira Health

Management Consulting

Market Opportunity Assessment and Growth Strategy

Actionable insights customized for your business

Find the right opportunities across Pharma, MedTech and Digital Health with Alira Health as your partner. You’ll benefit from comprehensive evaluations and action plans for market approach, access, prioritization, pricing, and challenges.

Strategy backed by research

Alira Health delivers market research based on objective data collection and analysis that targets growth, synergy, economy-of-scale, and revenue opportunities. We’re committed to delivering comprehensive, custom research that leverages a wide range of sources including:
  • Surveys and interviews from focus groups, industry experts, and key opinion leaders
  • Collaboration with clinicians, executives, hospital personnel, distributors, and administrators
  • Government, commercial markets, and global healthcare databases

Connect with a Winning Team

See why Alira Health was named one of the world’s best management consulting firms by Forbes.

Comprehensive assessment and planning

As our partner, you’ll work closely with our in-house market access and growth strategy experts to capture the full spectrum of your business goals. Together, we will:
  • Determine key capabilities to sustain and gain competitive advantages – and how to develop or acquire them
  • Map and prioritize the most promising short- and long-term growth opportunities
  • Outline value creation potential for core, adjacent and transformational opportunities in relation to current capabilities
  • Establish key success factors for selected opportunities and build high-level business cases for relevant segments
  • Identify promising targets for inorganic strategies, and, working with our Transaction Advisory practice, acquire targets

A unique four-step approach

Alira Health offers a comprehensive four-step process to identify, map, prioritize, and execute unique strategies to capitalize on market-leading opportunities.

Why choose Alira Health?

With Alira Health as your partner, you will benefit from:

  • Experience across the full healthcare ecosystem
  • Top talent from investment banks and the healthcare industry
  • Integrated market and growth strategy assessment tailored to your business goals

Related news

Articles July 4, 2024
Navigating Market Access for Rare Diseases: The Potential of Real-World Evidence
Our experts answer common questions about the strategic need for real-world evidence to drive market access for rare diseases.
Market Access Rare Disease Real-World Evidence (RWE)
Case Studies June 27, 2024
A Multinational Pharma Targeting Myasthenia Gravis Garners Payer Advice on Market Access
Our client sought to incorporate early payer advice on the MG clinical trial design, identify evidence gaps, and provide insights on the overall development program for the asset.
Market Access Myasthenia Gravis (MG) Rare Disease
Articles March 18, 2024
WHO Model Lists of Essential Medicines: What You Need to Know 
Our Market Access experts share the importance of the EML for pharma companies and four best practices for a successful application, based on our extensive experience in interactions with the WHO.
Market Access
Events February 20, 2024
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Market Access Pricing Real-World Evidence (RWE)
News January 24, 2024
Alira Health and AseBio Announce Market Access Mentoring Program for 2024
Alira Health and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.
Biotech Market Access Spain Startups
Case Studies January 18, 2024
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Market Access Pharma
News January 18, 2024
Alira Health and Biocat Announce Startup Support Program for 2024
Alira Health and Biocat, a strategic stakeholder building the Catalan life sciences and ecosystem, partnered to foster Market Access for startups.
Market Access Startups
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.